- Custom Health (CHLT:CA) signed a binding letter of intent to acquire Evergreen Pharmacy for $3.5M.
- Evergreen is a specialty pharmacy focused on high-touch care for patients with complex therapies and operates in Wisconsin, with licenses in Illinois and Michigan.
- The purchase price includes at least $1M in prescription drug inventory and $450,000 in net working capital, with a $175,000 indemnity holdback.
- Evergreen generated $78.8M in revenue and US$600,504 in normalized EBITDA in FY2025, and $19.6M in revenue and $150,504 in normalized EBITDA in Q1 2026.
- Evergreen reported positive net income in both FY2025 and Q1 2026.
- Custom Health expects the acquisition to increase revenue and profitability, expand its U.S. Midwest presence, and strengthen its specialty pharmacy and clinical services platform.
- The transaction is expected to close in Q3 2026.
Custom Health to acquire Evergreen Pharmacy for $3.5M
Custom Health (CHLT:CA) signed a binding letter of intent to acquire Evergreen Pharmacy for $3.5M. Evergreen is a specialty pharmacy focused on high-touch care for patients with complex therapies and operates in Wisconsin, with licenses in Illinois and Michigan. The purchase price includes at least $1M in prescription drug inventory and $450,000 in...